Every single type of cancer, explained A cancer diagnosis can be both terrifying and confusing for those afflicted, as well ...
Patient recounts IL‑2 therapy chills, rigors, ICU seizure scare, and recovery—what treatment feels like and why monitoring ...
Investigators analyzed the immune-modulatory cancer vaccine IO102-IO103 plus pembrolizumab for PFS in patients with untreated advanced melanoma.
On March 20, the FDA approved Opdivo for adult and pediatric patients (aged 12 years and older) with previously untreated ...
Learn about superficial spreading melanoma, from the ABCDE diagnostic rules to the latest in immunotherapy, targeted care and surgical options. Superficial spreading ...
Treatments based on genomic profiling can significantly extend survival for patients with advanced or rare cancer, but only ...
Immunocore reports first quarter financial results and provides a business update KIMMTRAK® (tebentafusp-tebn) Q1 net sales of $106.7 million, ...
Day One Biopharmaceuticals, Inc., now part of Servier Group, today announced that it has completed enrollment in the ...
In the ongoing Phase 2 AMPLIFY-7P study evaluating ELI-002 7P in patients with pancreatic ductal adenocarcinoma (“PDAC”), the event-driven ...
Preliminary insights from the Phase III trial are anticipated to be available in 2027.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results